Lakewood-Amedex Biotherapeutics Inc, a clinical-stage biotech firm focused on developing a new category of powerful, rapid-acting, broad-spectrum antimicrobials known as the Bisphosphocin® class, has announced the addition of Joseph Tucker, …
Yesway Inc, has announced the pricing of its initial public offering (IPO), consisting of 14,000,000 shares of Class A common stock at $20.00 per share. The company has also provided …
